Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zähringer, U.
Right arrow Articles by Rottem, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zähringer, U.
Right arrow Articles by Rottem, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 42, Issue of October 17, 1997 pp. 26262-26270
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Primary Structure of a New Phosphocholine-containing Glycoglycerolipid of Mycoplasma fermentans*

(Received for publication, February 25, 1997, and in revised form, June 4, 1997)

Ulrich Zähringer Dagger §, Frauke Wagner Dagger , Ernst Th. Rietschel Dagger , Gil Ben-Menachem , Joseph Deutsch par and Shlomo Rottem

From the Dagger  Research Center Borstel, Center for Medicine and Biosciences, Parkallee 22, D-23845 Borstel, Federal Republic of Germany, the  Department of Membrane and Ultrastructure Research, The Hebrew University-Hadassah Medical School, and the par  Department of Pharmaceutical Chemistry, School of Pharmacy, The Hebrew University, Jerusalem 91010, Israel

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

The chemical structure of a novel phosphocholine-containing glycoglycerolipid, the major polar lipid in the cell membrane of Mycoplasma fermentans PG18, was investigated by chemical analyses, gas-liquid chromatography-mass spectrometry, matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry, as well as one- and two-dimensional homo- and heteronuclear NMR spectroscopy and identified as 6'-O-(3"-phosphocholine-2"-amino-1"-phospho-1",3"-propanediol)-alpha -D-glucopyranosyl-(1'right-arrow3)-1,2-diacyl-glycerol (MfGL-II). Palmitate (16:0) and stearate (18:0), in a 3.6:1 molar ratio, constitute the major fatty acids present. MALDI-TOF mass spectrometry revealed two major pseudomolecular ions at m/z 1049.5 [MI + H]+ and 1077.3 [MII + H]+ representing a dipalmitoyl as the major component and a palmitoyl-stearoyl structure as a minor component. This is the first report of 2-amino-1,3-propanediol-1,3-bisphosphate present in a natural product. This glycoglycerolipid is the second phosphocholine-containing glycoglycerolipid found in M. fermentans.


INTRODUCTION

The human pathogen Mycoplasma fermentans PG18 was isolated from the urogenital tract several decades ago (1). Because of reports indicating its possible role as a cofactor accelerating the progression of human immunodeficiency virus disease, its significance as a pathogen in other immunocompromised patients (2), and its role in the pathogenesis of rheumatoid arthritis, interest in M. fermentans has recently increased (3). Although little is known of the molecular mechanisms underlying M. fermentans pathogenicity (4), it has been shown that human immunodeficiency virus-associated cytopathic effects could be increased by the presence of M. fermentans (2) and that M. fermentans is capable of fusing with T-cells and peripheral lymphocytes (5).

It is reasonable to assume that Mycoplasma membrane components are involved in the attachment and fusion of the microbe with eukaryotic host cells. Salman et al. (6) isolated an unusual phospholipid from the cell membranes of M. fermentans and showed that this material (compound X) was capable of enhancing the fusion of small, unilamellar vesicles with MOLT-3 lymphocytes in a dose-dependent manner.

Matsuda et al. (4) isolated two glycoglycerolipids (GGPL-I1 and GGPL-III) from M. fermentans. GGPL-I structure was shown to be 6'-O-phosphocholine-alpha -D-glucopyranosyl-1,2-diacyl-sn-glycerol (7) as elucidated by mass and NMR spectroscopy. It was later shown (4) that the structure of a more polar glycolipid (GGPL-III) isolated from the same strain of M. fermentans was very similar to that of GGPL-I. The chemical structure of GGPL-III, however, has so far remained obscure. The only distinguishing structural feature known is that it differs from GGPL-I in having an additional amino residue (4). Both GGPLs were shown to be species-specific major lipid antigens of M. fermentans (4).

Here we describe the structural analysis of a new type of polar lipid isolated from M. fermentans, and we present the complete structural analysis of MfGL-II.2 Furthermore, we show that both glycolipids of M. fermentans, GGPL-I and GGPL-III, share the basic structure of 6'-O-phospho-alpha -D-glucopyranosyl-(1'right-arrow3)-1,2-diacyl-glycerol (7) but differ in their polar head groups.


MATERIALS AND METHODS

Growth of the Organism

Cultures of M. fermentans strain PG18 and strain Incognitus (provided by S.-C. Lo, Armed Forces Institute of Pathology, Washington, D.C.) were grown in a modified Channock medium (8) inoculated with a 48-h culture at an inoculum level of 2% and incubated statically at 37 °C. After 68 h the cells were harvested, washed twice, and freeze-dried as described previously (8) with yields ranging from 130 to 160 mg dry weight per liter of medium.

Lipid Extraction and Purification

Freeze-dried cells were suspended in 25 mM Tris/HCl, pH 7.5, containing 0.25 M NaCl to a final concentration of 25 mg of cells per ml. Lipids were extracted from cell suspensions by the method of Bligh and Dyer (9) and concentrated to near dryness on a rotary evaporator. Quantitative separation of MfGL-II was achieved by silica gel column chromatography. Total lipid was redissolved in 2 ml of chloroform and loaded onto a silica gel column (1.5 × 3 cm; Kieselgel 60, 230-400 mesh, Merck), equilibrated with chloroform and sequentially eluted with four bed volumes of chloroform (fraction 1), chloroform/methanol, 1:4 (v/v, fraction 2), chloroform/methanol/water, 1:4:0.7 (fraction 3), chloroform/methanol/water, 1:4:1 (fraction 4), chloroform/methanol/water, 1:4:1.5 (fraction 5), chloroform/methanol/water, 1:8:3 (fraction 6), methanol (fraction 7), methanol/water, 7:3 (fraction 8), and methanol/water, 6:4 (fraction 9). Fractions were vacuum evaporated to dryness, redissolved in 0.5 ml of elution solution, and analyzed by thin layer chromatography. Since fractions 4-7 contained pure MfGL-II they were combined and dialyzed in 10 mM EDTA against water for 4 days at 4 °C.

Mild Methanolysis

MfGL-II (370 µg) was dissolved in 0.5 M HCl/MeOH and incubated at 85 °C for 40 min. The solvent was removed under a stream of nitrogen, and the liberated fatty acid methyl esters were analyzed by GLC and GLC-MS.

Strong Methanolysis and Peracetylation

Following mild methanolysis, samples were dissolved in 2 M HCl/MeOH, incubated at 85 °C for 16 h, and peracetylated with acetanhydride/pyridine (1:2, v/v) for 60 min at 85 °C. Carbohydrates and other components of MfGL-II were analyzed as their peracetylated derivatives by GLC and GLC-MS.

Dephosphorylation

MfGL-II (290 µg) and derived phosphomethyl ester were dephosphorylated by treatment with 48% aqueous HF at 4 °C for 36 h. Following solvent removal in vacuo over KOH, the product was peracetylated and analyzed as described earlier.

Synthesis of 2-Amino-1,3-propanediol

D-Serine (Sigma) was methylated by acidic methanolysis (0.5 M HCl/MeOH, 85 °C, 40 min), and the resulting methyl ester was reduced with NaBH4 in methanol/water (1:1, v/v) to the corresponding 2-amino-1,3-propanediol which was then peracetylated and analyzed by GLC-MS.

Methylation Analysis

MfGL-II (1.3 mg, 1.2 µmol) was per-N,O-acetylated with acetanhydride/pyridine (1:2, v/v) at room temperature for 16 h in the dark followed by O-deacylation with 0.3 ml of 0.25 M NaOCH3 (75 µmol) in absolute methanol at 37 °C for 3 h prior to methylation analysis. The pH was adjusted to 4 with 0.1 M HCl/MeOH, and the phosphates were transformed to methyl esters with ethereal diazomethane (CH2N2) treatment at room temperature for 15 min. The solvents were removed under a stream of nitrogen, and the product was washed three times with ether/n-hexane (10:90, v/v) to remove liberated fatty acids. The sample was dried in vacuo and methylated (10). The permethylated sample was extracted with water/chloroform (7 ml, 6:1, v/v); the aqueous layer was washed twice with 1 ml of chloroform, and the combined organic phases were washed again with 100 ml of water and taken to dryness under a stream of nitrogen. After methylation the product was dephosphorylated as described earlier, and an aliquot was directly peracetylated (see above) and analyzed by GLC-MS.

The phosphate position in the glucose moiety was determined with another aliquot. MfGL-II was hydrolyzed (4 M trifluoroacetic acid, 100 °C, 4 h), and the solvent was removed on a rotary evaporator. The product was redissolved in water/methanol (10:1, v/v), and the pH was adjusted to neutral with NaOH. The sample was then reduced (NaBD4) at room temperature overnight in the dark. The resulting product was peracetylated and analyzed by GLC-MS.

O-Deacylation

MfGL-II (12.4 mg, 11.8 µmol) was O-deacylated with 0.33 ml of 0.25 M NaOCH3 (82.5 µmol) in absolute methanol at 40 °C. The reaction course was followed by TLC (chloroform/methanol/water, 100:100:30, v/v). After 1 h no MfGL-II (RF = 0.38) and no lysoforms (RF = 0.16) were found, and a single spot remained at the origin. The solvent was reduced to near dryness under a stream of nitrogen, and 2 ml of chloroform/water (1:1, v/v) were added. The organic layer was washed twice with 2 ml of water, and the combined aqueous phases were loaded onto a Sephadex G-10 column (2 × 112 cm) and eluted with water. The fractions were analyzed by the anthrone test (11), and positive fractions were combined, freeze-dried (yield 6.7 mg, quantitative), and analyzed by NMR.

Thin Layer Chromatography

For TLC aluminum sheets of pre-coated silica gel 60 F254 thickness 0.2 mm (Merck) were used. The plates were developed at room temperature with chloroform/methanol/water, 100:100:30 (v/v). Glycolipid spots were detected by dipping the plates into a solution of 15% sulfuric acid in ethanol and heating to 110 °C for 2 min. Phospholipid spots were detected by the Dittmer-Lester reagent (12) diluted with acetone (1:20, v/v). Amino groups containing lipids were detected by dipping the plates into a solution of 0.2% ninhydrin in acetone followed by heating to 60 °C for 15 min.

Gas-Liquid Chromatography

GLC was performed with a Varian model 3700 chromatograph equipped with a capillary column of SPB-5 using a temperature gradient from 150 to 320 °C with a temperature rise of 5 °C/min.

GLC-Mass Spectrometry

GLC-MS was carried out with a Hewlett-Packard model 5989 equipped with a capillary column (HP-5) under the same conditions as GLC. The ion source temperature was 200 °C. EI-mass spectra were recorded at 70 eV and CI-mass spectra were obtained with ammonia as reactant gas.

Matrix-assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) Mass Spectrometry

MALDI-TOF mass spectra of positive ions were recorded with a Reflex II, Bruker-Franzen (Bremen, Germany) spectrometer in the linear mode (MALDI-LIN-TOF) at 28.5 kV acceleration voltage using 2,5-dihydroxybenzoic acid as matrix. The spectra were obtained from 0.5 µl of a 1:1 (v/v) mixture of aqueous matrix solution (25 mg of 2,5-dihydroxybenzoic acid in 500 µl) and native MfGL-II (1 µg/µl in chloroform/methanol, 1:1, v/v).

Nuclear Magnetic Resonance (NMR) Spectroscopy

NMR spectra were obtained with a Bruker AM-360 spectrometer. Spectra of native MfGL-II (20 mg) were recorded in 10:10:3 (CDCl3:MeOD:D2O, v/v, 0.5 ml) and referenced to delta H = 7.26 ppm (CDCl3) and delta C = 77.0 ppm (CDCl3), respectively. 1H NMR spectra were measured at 360 MHz (13C NMR, 90.5 MHz); 31P NMR spectra were measured over a spectral range of 20,000 Hz with both 1H broad band coupling and decoupling. The spectrometer frequency was 145.78 MHz. 31P NMR signals were referenced to an 80% (mass/volume) solution of H3PO4 as an external standard. The spectra of O-deacylated MfGL-II (6.7 mg) were recorded in 0.5 ml of D2O and referenced to delta H = 2.225 ppm and delta C = 31.45 ppm (external acetone). One- and two-dimensional homonuclear (1H,1H COSY, ROESY, and relayed COSY) and two-dimensional H-detected 1H,13C HMQC and 1H,31P HMQC experiments were performed using standard Bruker (Rheinstetten, Germany) software (XWINNMR, version 1.1). The coupled and decoupled 31P NMR spectra and the 1H,31P HMQC spectrum were recorded with O-deacylated MfGL-II in D2O at room temperature.


RESULTS

Isolation of MfGL-II

The MfGL-II of M. fermentans (Incognitus strain) was obtained from 1.2 g of dry cells after Bligh and Dyer extraction. It was purified to homogeneity by silica gel column (1.5 × 3 cm, Kieselgel 60, Merck) eluted stepwise with mixtures of chloroform/methanol/water and methanol/water with increasing polarity (fractions 4-7).

The yield of MfGL-II from 134 mg of total lipids was 21 mg of MfGL-II (15.7%) and, thus, the MfGL-II is a major lipid in the membrane of M. fermentans. High levels of MfGL-II were also found with the PG18 strain. As the yields of biomass from the PG18 strain were much higher, all subsequent experiments were performed with this strain.

Fatty Acid Analysis

The MfGL-II was found to be degraded by mild acidic methanolysis indicating that the fatty acids were ester-linked. Methyl palmitate (16:0) and methyl stearate (18:0) were identified as the major fatty acids in a molar ratio of 3.6:1 similar to that described previously (8).

Compositional Analysis of MfGL-II by GLC and GLC-MS Analyses

Strong methanolysis (2 M HCl/MeOH, 85 °C, 16 h), dephosphorylation (48% HF), and peracetylation revealed, upon GLC-MS analysis, methyl hexose with the same retention time and fragmentation pattern (EI-MS) as peracetylated methyl alpha -D-glucose. In addition to the glucose, an N-containing substance as deduced from its odd-number molecular mass, Mr = 217, in CI-MS ([M + H]+ = 218, [M + NH4]+ = 235) expressed a retention time and molecular weight being compatible with 1,3-di-O-acetyl-2-acetamido-propanediol. Since 2-amino-1,3-propanediol was not yet identified in Mycoplasma, we tried to corroborate this analysis by a simple chemical synthesis for reference material starting from D-serine which was methylated, reduced, and per-O-acetylated (see "Materials and Methods"). With GLC-MS analysis the resulting compound showed identical retention time and fragmentation pattern (EI-MS (Fig. 1) as well as CI-MS (spectra not shown)), thus substantiating the original assignment.


Fig. 1. Electron impact mass spectra of 1,3-di-O-acetyl-2-acetamidopropanediol. A, N-containing substance derived from MfGL-II; B, synthetic substance.
[View Larger Version of this Image (17K GIF file)]

GLC-MS analysis after dephosphorylation and peracetylation revealed a structure with a molecular weight of 506 (CI-MS) corresponding to glucose with glycosidically linked glycerol, thus indicating that glucose is directly bound to glycerol. The 2-amino-1,3-propanediol moiety was found as 1,3-di-O-acetyl-2-acetamido-propanediol derivative identical to that of the synthetic 2-amino-1,3-propanediol described above, thus indicating that 2-amino-1,3-propanediol is involved in the structure of MfGL-II as a phosphoester.

Methylation analysis of native MfGL-II (N-acetylation, deacylation, methylation (10), dephosphorylation (48% HF), hydrolysis (trifluoroacetic acid), and reduction (NaBD4)) was done in two steps. First, after methylation and dephosphorylation an aliquot of the sample was peracetylated and subjected to GLC-MS analysis. The EI-MS spectra revealed a fragmentation pattern corresponding to 1,2-di-O-methyl-3-O-(O-acetyl-tri-O-methyl-glucopyranosyl)glycerol (peaks at m/z 247 assigned to the glucopyranoside moiety and at m/z 103 assigned to the glycerol moiety with the typical McLafferty rearrangement at m/z 163 (spectra not shown)) indicating that glucose was substituted with one phosphate. In addition, 1,3-di-O-acetyl-2-(N-methylacetamido)propanediol was detected suggesting that the 2-amino-1,3-propanediol moiety was symmetrically substituted with two phosphates (spectra not shown). To identify the position of the phosphate residue on the glucopyranosyl moiety, the sample was hydrolyzed and reduced yielding 1,5,6-tri-O-acetyl-2,3,4-tri-O-methyl-glucitol (spectra not shown), indicating the presence of a 6-phosphate on the glucopyranosyl moiety.

These findings suggested a linear structure of diacyl-glyceryl-glucopyranoside with 6'-O-(2"-amino-1",3"-diphospho-1",3"-propanediol)-alpha -D-glucopyranosyl-(1'right-arrow3)-glycerol as the hydrophilic backbone (Fig. 2).


Fig. 2. Partial structure of MfGL-II. After methylation analysis (see "Materials and Methods"), a structure of 6'-O-(2"-amino-1",3"-diphospho-1",3"-propanediol)-alpha -D-glucopyranosyl-(1'right-arrow3)-glycerol was suggested.
[View Larger Version of this Image (9K GIF file)]

Because the phosphocholine moiety in native MfGL-II was not accessible by methylation analysis and GLC-MS spectrometry other analytical procedures were used.

MALDI-TOF Mass Spectrometry

The molecular size of underivatized MfGL-II was investigated by MALDI-LIN-TOF mass spectrometry in the positive ion mode. Native MfGL-II showed two major pseudomolecular ions (m/z 1049.5 [MI + H]+ and m/z 1077.3 [MII + H]+) (Fig. 3) with various pseudomolecular ions having Na+ and K+ attached to MI and MII, respectively. The difference between the molecular weights (Delta m/z = 28) suggested the presence of two molecular species expressing variability in the fatty acid components, representing a dipalmitoyl derivative of MfGL-II as the major component and a palmitoyl-stearoyl derivative as a minor component, respectively. The molecular weight of MI ([MI + H]+ = 1049.5) is consistent with the formula C49H99O17N2P2 and also with the structure shown in Fig. 8.


Fig. 3. Part of the MALDI-LIN-TOF mass spectrum of the native MfGL-II. Two major peaks of pseudomolecular ions [M + H]+ at m/z 1049.5 and 1077.3 represent dipalmitoyl (MI) and palmitoyl-stearoyl (MII) derivatives. Other peaks could be assigned to pseudomolecular ions [M + Na+] and [M + K+] of MI and MII, respectively.
[View Larger Version of this Image (11K GIF file)]


Fig. 8. Structure of the main fraction of native MfGL-II. 6'-O-[(3"-Phosphocholine-2"-amino-1",3"-propanediol)-alpha D-glucopyranosyl](1'right-arrow3)-1,2-dipalmitoyl-sn-glycerol.
[View Larger Version of this Image (6K GIF file)]

The presence of different fatty acid residues in the glycerol moiety was further supported by detecting methyl palmitate and methyl stearate in the GLC-MS analysis (see above). These findings were in good agreement with previous reports on fatty acid composition of MfGL-II (8).

NMR Spectroscopy

The structure of the MfGL-II was further elucidated by different NMR experiments on native as well as on O-deacylated MfGL-II. The results are summarized in Table I for 1H signals and in Table II for 13C signals. The assignment of various signals produced by one- and two-dimensional homo- and heteronuclear NMR spectroscopy (Fig. 4, Fig. 5) were in good agreement with those of the diacyl-(glycosyl-6-phosphate)glycerol moiety recently identified in M. fermentans by Matsuda et al. (7).

Table I. 1H chemical shifts of native and O-deacylated MfGL-II

For solvents and references see "Materials and Methods." For fatty acid residues the chemical shifts (in ppm) are as follows: H-2, 2.24; H-3, 1.52; H-4 to H-15, 1.18; and H-16, 079. 

Residue Glucoglycerolipid Chemical shifts [ppm] and coupling constants [Hz]
H-1a H-1b H-2 H-3(a) H-3b H-4 H-5 H-6a H-6b

Gro (A)   Native 3.99a 4.35 5.20 3.56 3.72
(J1a,1b 12.1) (J1b,2 2.4) (J3a,3b 10.8) (J3b,2 5.5)
  O-Deacylated 3.60a 3.69 3.96a 3.50 3.83
(J1a,1b 11.7) (J1b,2 4.4) (J3a,2 2.5) (J3a,3b 10.5) (J3b,2 3.7)
Glc (B)   Native 4.74 3.37 3.57 3.43 3.55 3.90 4.08
(J1,2 3.4) (J2,3 9.7) (J3,4 9.2) (J4,5 9.3) (J5,6a 5.1) (J6a,6b 11.5) (J5,6b 7.4)
  O-Deacylated 4.94 3.59 3.75 3.50 3.81 4.08a 4.12a
(J1,2 4.0) (J2,3 9.5) (J3,4 9.5)
AP (C)   Native 3.97b 3.97b 3.60 4.03b 4.03b
  O-Deacylated 3.96a,b 3.96a,b 3.35 3.96a,b 3.96a,b
Cho (D)   Native 4.21a 4.21a 3.56a 3.12c
  O-Deacylated 4.33a 4.33a 3.68a 3.23c

a Nonresolved multiplet.
b Assignments in one line may have to be reversed.
c Singlet -N+(CH3)3, (integral 9H).

Table II. 13C chemical shifts of native and O-deacylated MfGL-II

For solvents and references see "Materials and Methods." For fatty acid residues the chemical shifts (in ppm) are as follows: C-1, 173.72, and 173.47; C-2, 33.67 and 33.52; C-3, 24.37 and 24.28; C-4 to C-13, 28.79 to -28.54; omega -1, 22.02; omega -2, 31.29; and omega , 13.23. 

Residue Glucoglycerolipid Chemical shifts [ppm] and (heteronuclear coupling constants [Hz])
C-1 C-2 C-3 C-4 C-5 C-6

Gro (A)  Native 62.43 69.59 65.69
 O-Deacylated 63.59 71.82 70.22
Glc (B)  Native 98.95 71.13 72.43 68.36 70.70 63.38
 O-Deacylated 100.01 72.61 74.09 70.28 71.95 65.40
AP (C)  Native 62.01a 51.21 61.82a
(JC-1,P 4.9) (JC-2,P 7.1/7.7) (JC-3,P 4.4)
 O-Deacylated 66.65 51.84 66.43
(JC-1,P 4.9) (JC-2,P 8.2/7.7) (JC-3,P 4.4)
Cho (D)  Native 58.90 65.61 53.36
 O-Deacylated 60.66 67.19 55.16

a Assignments may have to be reversed.


Fig. 4. Part of the two-dimensional 1H,1H COSY spectrum of the native MfGL-II. Cross-peaks are shown for the glucosyl (B), 2-amino-1,3-propanediol (C), and choline (D) residues. The corresponding part of the 1H NMR spectrum is displayed along the horizontal axis. For numbering of protons see Table I.
[View Larger Version of this Image (47K GIF file)]


Fig. 5. Two-dimensional H-detected 1H,13C HMQC spectrum of the native MfGL-II. A, the whole spectrum with the assignment of the signals of the glycerol moiety (A) and fatty acids (FA); B, extension of the area shown in A by rectangle with the assignment of the signals of the glucosyl (B), 2-amino-1,3-propanediol (C), and choline (D) residues. The corresponding parts of the 1H and 13C NMR spectra are displayed along the horizontal and vertical axes, respectively. For numbering of atoms see Tables I and II.
[View Larger Version of this Image (24K GIF file)]

In the O-deacylated MfGL-II, the resonances of H-1aGro, H-1bGro, and H-2Gro were shifted upfield (Table I), whereas the positions of resonances of the other glycerol proton signals (H-3aGro and H-3bGro) were unchanged. These findings indicated that the glycosyl moiety is linked to O-3Gro as is found in an aminophosphoglycolipid of Clostridium innocuum (13).

The alpha -anomeric configuration of the hexose was inferred by the coupling constant J1,2 of 3.4 Hz. The other coupling constants of the hexose (J2,3, J3,4, and J4,5) were larger than 8 Hz, indicating an alpha -glucopyranoside configuration. The chemical shifts of C-2Glc, C-3Glc, C-4Glc, C-5Glc, and C-6Glc as well as the coupling constant J6a,6b were similar to those of alpha -glucose 6-phosphate (14), providing evidence that a phosphate group was bonded to the O-6 hydroxyl of glucose. A ROESY experiment with O-deacylated MfGL-II showed nuclear Overhauser effects between H-1Glc and both H-3aGro and H-3bGro indicating a close proximity of these protons consistent with an alpha -(1'right-arrow3) linkage (Fig. 6).


Fig. 6. Parts of the two-dimensional ROESY (left) and 1H,1H COSY (right) spectra of the O-deacylated MfGL-II with cross-peaks of the anomeric proton of the glucosyl residue (B). The corresponding parts of the 1H NMR spectrum are displayed along the axes.
[View Larger Version of this Image (17K GIF file)]

The assignment of the 1H NMR and 13C NMR signals was done by 1H,1H COSY and 1H,13C COSY experiments in which the assignment of C-1AP and C-3AP may be interchanged because it was not possible to distinguish clearly between these carbon signals. The C-2AP signal in the native MfGL-II was a doublet of doublet with two similar heteronuclear coupling constants of JC-2,P 7.1 Hz and JC-2,P' 7.7 Hz, respectively, indicating that the 2-amino-1,3-propanediol is symmetrically substituted by two phosphate residues. The chemical shifts, except those for C-3AP and H-3a,bAP, approximated the values reported for a phosphoglycolipid isolated from the taxonomically closely related C. innocuum, which contained a 1-phosphate-2-amino-1,3-propanediol at O-6 of alpha -galactopyranosyl moiety (13). The differences for C-3AP and H-3a,bAP indicated that in the MfGL-II the 2-amino-1,3-propanediol moiety is substituted at O-3, whereas in the phosphoglycolipid of C. innocuum it was not.

The H-1Cho signal at 4.21 ppm coupled with the H-2Cho signal appeared as a superposition with other signals. The -N+(CH3)3 group was assigned to an intense signal (integral 9H) at 3.12 ppm. The chemical shifts were very close to the values reported for GGPL-I containing a choline phosphate group at O-6 of alpha -glucosyl moiety (7).

The 1H and 13C NMR signals of the ester-linked fatty acids, summarized in Tables I and II, were in the expected range (13). Also present in the 1H NMR spectrum were signals of olefinic protons (5.25-5.26 ppm) corresponding to unsaturated fatty acids. This finding agrees well with data from GLC and GLC-MS indicating trace amounts of unsaturated fatty acids (18:1).

Different experiments were performed to determine the position of the phosphate groups in MfGL-II. Various one-dimensional and two-dimensional 31P NMR experiments of native MfGL-II measured in 100:100:30 (CDCl3:MeOD:D2O, v/v) gave no satisfactory resolution for the 31P signals. Therefore, the phosphate linkages were determined with O-deacylated MfGL-II. The broad band-decoupled 31P NMR spectrum of the O-deacylated MfGL-II showed two singlets at 1.09 and 0.08 ppm, respectively (spectrum not shown). However, in the proton-coupled gated 31P NMR spectrum, the two phosphate groups gave identical multiplets due to the coupling with two structurally related methylene protons (O-CH2Glc and O-CH2AP versus O-CH2AP and O-CH2Cho). The signal intensities upon integration matched precisely the theoretically expected binomial coefficient of 1:4:6:4:1 (found, 1.0:4.3:6.4:4.4:1.3). This splitting is typical for phosphate groups symmetrically substituted with two methylene groups. From these data it was concluded that in MfGL-II four methylene groups are attached to two phosphate residues: one from choline, two from the 2-amino-1,3-propanediol, and one from the Glc residue. The 1H,31P HMQC spectrum (Fig. 7) revealed unambiguously the linkage of the phosphate groups. Both 31P signals (P-1 and P-2) showed highly complex cross-peaks. The 31P signal at 1.09 ppm (P-1) correlated with a multiplet of H-1a,bAP (~3.96 ppm) and with the H-6aGlc and H-6bGlc signals (~4.08 and ~4.12 ppm, respectively). The other 31P signal (P-2) at 0.08 ppm showed cross-peaks with a multiplet of H-3a,bAP (~3.96 ppm) and with the H-1a,bCho signal (4.33 ppm).


Fig. 7. Two-dimensional H-detected 1H,31P HMQC spectrum of the O-deacylated MfGL-II. Cross-peaks with the phosphate groups (P-1 and P-2) are shown for the glucosyl (B), 2-amino-1,3-propanediol (C), and choline (D) residues. The corresponding parts of the 1H and 31P NMR spectra are displayed along the horizontal and vertical axes, respectively. For numbering of atoms see Table I.
[View Larger Version of this Image (13K GIF file)]

Taken together these findings confirmed the structure of the MfGL-II as 6'-O-(3"-phosphocholine-2"-amino-1"-phospho1",3"-propanediol)-alpha -D-glucopyranosyl-(1'right-arrow3)-1,2-diacyl-glycerol. The results of the chemical analyses, GLC-MS analyses with synthetic reference compounds, MALDI-TOF mass spectrometry and various NMR experiments, described above were identical with those obtained by analyzing the MfGL-II of M. fermentans incognitus strain. The best structure suggested by these results is shown in Fig. 8.


DISCUSSION

The role of AIDS-associated M. fermentans in the pathogenesis of the disease has not been yet defined. An interesting hypothesis is based on the ability of M. fermentans to fuse with lymphocytes (5). It has been suggested that Mycoplasma components released to the lymphocyte upon Mycoplasma-lymphocyte fusion adversely affected lymphocyte function (6). The fusogenicity of M. fermentans cells is correlated with a membrane-associated MfGL-II (6); although several studies have investigated the chemical nature of this lipid, there is presently no consensus on the chemical structure. We have addressed this issue with the aim to establish unequivocally the primary structure of the MfGL-II previously designated as compound X (6, 8) or GGPL-III (7).

MfGL-II was isolated from dried cells of M. fermentans PG18 using the extraction protocol described previously (8). Using various analytical procedures (GLC, MALDI-TOF mass spectrometry, and NMR spectrometry), we showed that while both compounds were isolated by identical procedures, the structure proposed (8) has to be revised. We have unequivocally identified the structure of the major polar membrane lipid of M. fermentans PG18 as 6'-O-(3"-phosphocholine-2"-amino1",3"-propanediol)-alpha -D-glucopyranosyl-(1'right-arrow3)-1,2-dipalmitoyl-glycerol (MfGL-II).

MfGL-II shows high structural homology to GGPL-I (MfGL-I), a phosphocholine-containing glyceroglycolipid from M. fermentans (7). The main difference between GGPL-I and MfGL-II is the presence of a 2-amino-1,3-propanediol moiety and an additional phosphate residue. Matsuda et al. (4) described another phosphocholine-containing glycoglycerolipid which they termed GGPL-III and postulated to possess a structure very similar to GGPL-I but harboring an additional amino group (4). Our data and those presented by Matsuda et al. (4) show that GGPL-III and the MfGL-II could be structurally identical compounds.

It is of great interest that in both MfGL-I and MfGL-II the phosphocholine moiety is the terminal, exposed structural motif. As the two glycoglycerolipids constitute the major lipid fraction of the M. fermentans PG18 membrane, it appears likely that phosphocholine is a key structure in cellular adhesion of M. fermentans to host cells.

Phosphocholine has recently been reported to be a constituent of the glycosphingolipid of the annelid Pheretima hilgendorfi (15), of lipoteichoic acid (16), and of the cell wall associated teichoic acid of Streptococcus pneumoniae (17). In Haemophilus influenzae phosphocholine was also identified on the surface and was found to be attached to the lipopolysaccharide (18, 19). All bacteria having phosphocholine as part of their surface structures colonize the human nasopharynx. This observation supports the assumption that phosphocholine plays a key role in potentiating microorganism-host interaction.

There are reports that the human C-reactive protein, an acute phase protein, has the ability to bind to phosphocholine-containing pneumococcal C-polysaccharide (20). This complex activates the complement system. Thus, bacteria-associated choline appears to play an important role not only in cellular adhesion but also in subsequent inflammatory reactions.

The 2-aminol-1,3-diphosphate-1,3-propanedio group has so far not been identified in nature. Fischer et al. (13) described a 2-amino-1,3-propanediol-3-phosphate-carrying diradylglyceroglycolipid as a major membrane lipid of C. innocuum. Interestingly, Clostridia are taxonomically closely related to Mycoplasma (21), and it is tempting to speculate that in both organisms the 2-amino-1,3-propanediol is formed by transamination of dihydroxyacetone, a known intermediate of glycolysis (13). This indicates that in M. fermentans glucose has at least two possible fates as follows: catabolic, for energy metabolism, and anabolic, for the biosynthesis of structural molecules.

Recently 2-amino-1,3-propanediol has been detected as an O-antigen component of the lipopolysaccharide of Vibrio cholerae H11. Here, however, this moiety is linked by an amide bond to the carboxyl group of D-galacturonosyl residues (22).

While studies are needed to elucidate the molecular basis for mycoplasmal adhesion to host cells, the finding of phosphocholine as a terminal structure represents an important step toward understanding the molecular mechanism of the pathogenicity of M. fermentans.


FOOTNOTES

*   This work was supported by the German-Israeli Foundation for Scientific Research and Development, the Fonds der Chemischen Industrie (EThR), and the Deutsche Forschungsgemeinschaft Grants SFB 367, B2; SFB 470, B4 and B5.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   To whom correspondence and reprint requests should be addressed. Tel.: 49-4537-188462; Fax: 49-4537-188612; E-mail: uzaehr{at}f2borstel.de.
1   The abbreviations used are: GGPL, glycoglycerophospholipid; MfGL, M. fermentans glycolipid; GLC-MS, gas-liquid chromatography-mass spectrometry; MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight; MALDI-LIN-TOF, matrix-assisted laser desorption/ionization time-of-flight recorded in the linear mode; EI-MS, electron impact-mass spectrometry; CI-MS, chemical ionization-mass spectrometry; COSY, correlated spectroscopy; ROESY, rotating frame Overhauser enhancement spectroscopy; HMQC, heteronuclear multiple-quantum coherence; Gro, glycerol; Glc, glucose; AP, 2-amino-1,3-propanediol; Cho, choline; HF, hydrofluoric acid.
2   Unfortunately there exists a confusing terminology in the literature concerning these biologically significant polar glycolipids. We propose replacing the equivalent terms GGPL-I (also called lipid v (4)) with MfGL-I and replacing the equivalent terms GGPL-III = lipid vi (4) = compound X (6) with MfGL-II. The Roman numerals indicate the sequence of their discovery and structural description.

ACKNOWLEDGEMENTS

We thank H. Moll for GLC-MS analyses and chemical synthesis, H.-P. Cordes for NMR analyses, and Dr. B. Lindner and H. Lüthje for measuring the MALDI-TOF spectra. We also thank Dr. E. Lüneberg (University of Würzburg) for help in cultivating M. fermentans. We are indebted to Drs. Y. A. Knirel and R. L. Pardy for critically reading the manuscript.


REFERENCES

  1. Wise, K. S., Kim, M. F., Theiss, P. M., and Lo, S.-C. (1993) Infect. Immun. 61, 3327-3333 [Abstract/Free Full Text]
  2. Blanchard, A., and Montagnier, L. (1994) Annu. Rev. Microbiol. 48, 687-712 [CrossRef][Medline] [Order article via Infotrieve]
  3. Slomiany, B. L., Slomiany, A., and Glass, G. B. J. (1977) Eur. J. Biochem. 78, 33-39 [Medline] [Order article via Infotrieve]
  4. Matsuda, K., Harasawa, R., Li, J.-L., Kasama, T., Taki, T., Handa, S., and Yamamoto, N. (1995) Microbiol. Immunol. 39, 307-313 [Medline] [Order article via Infotrieve]
  5. Franzoso, G., Dimitrov, D. S., Blumenthal, R., Barile, M. F., and Rottem, S. (1992) FEBS Lett. 303, 251-254 [CrossRef][Medline] [Order article via Infotrieve]
  6. Salman, M., Deutsch, J., Tarshis, M., Naot, Y., and Rottem, S. (1994) FEMS Microbiol. Lett. 123, 255-260 [CrossRef][Medline] [Order article via Infotrieve]
  7. Matsuda, K., Kasama, T., Ishizuka, I., Handa, S., Yamamoto, N., and Taki, T. (1994) J. Biol. Chem. 269, 33123-33128 [Abstract/Free Full Text]
  8. Deutsch, J., Salman, M., and Rottem, S. (1995) Eur. J. Biochem. 227, 897-902 [Medline] [Order article via Infotrieve]
  9. Bligh, E. G., and Dyer, W. J. (1959) Can. J. Biochem. Physiol. 37, 911-917
  10. Ciucanu, I., and Kerek, F. (1984) Carbohydr. Res. 131, 209-217 [CrossRef]
  11. Shields, R., and Burnett, W. (1960) Anal. Chem. 32, 885-886 [CrossRef]
  12. Dittmer, J. C., and Lester, R. L. (1964) J. Lipid Res. 5, 126-127
  13. Fischer, W., Hartmann, R., Peter-Katalinic, J., and Egge, H. (1994) Eur. J. Biochem. 223, 879-892 [Medline] [Order article via Infotrieve]
  14. Bock, K., and Pedersen, C. (1983) Adv. Carbohydr. Chem. Biochem. 41, 27-66 [CrossRef]
  15. Sugita, M., Fujii, H., Inagaki, F., Suzuki, M., Hayata, C., and Hori, T. (1992) J. Biol. Chem. 267, 22595-22598 [Abstract/Free Full Text]
  16. Behr, T., Fischer, W., Peter-Katalinic, J., and Egge, H. (1992) Eur. J. Biochem. 207, 1063-1075 [Medline] [Order article via Infotrieve]
  17. Fischer, W., Behr, T., Hartmann, R., Peter-Katalinic, J., and Egge, H. (1993) Eur. J. Biochem. 215, 851-857 [Medline] [Order article via Infotrieve]
  18. Weiser, J. N., Shchepetov, M., and Chong, S. T. H. (1997) Infect. Immun. 65, 943-950 [Abstract]
  19. Risberg, A., Schweda, E. K. H., and Jansson, P.-E. (1997) Eur. J. Biochem. 243, 701-707 [Medline] [Order article via Infotrieve]
  20. Volanakis, J. E., and Kaplan, M. H. (1971) Proc. Soc. Exp. Biol. Med. 136, 612-614 [CrossRef][Medline] [Order article via Infotrieve]
  21. Johnston, N. C., Goldfine, H., and Fischer, W. (1994) Microbiology 140, 105-111 [Abstract/Free Full Text]
  22. Vinogradov, E. V., Holst, O., Thomas-Oates, J. E., Broady, K. W., and Brade, H. (1992) Eur. J. Biochem. 210, 491-498 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
G. Holzl, M. Leipelt, C. Ott, U. Zahringer, B. Lindner, D. Warnecke, and E. Heinz
Processive lipid galactosyl/glucosyltransferases from Agrobacterium tumefaciens and Mesorhizobium loti display multiple specificities
Glycobiology, September 1, 2005; 15(9): 874 - 886.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Yavlovich, A. Katzenell, M. Tarshis, A. A.-R. Higazi, and S. Rottem
Mycoplasma fermentans Binds to and Invades HeLa Cells: Involvement of Plasminogen and Urokinase
Infect. Immun., September 1, 2004; 72(9): 5004 - 5011.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Ben-Menachem, J. Kubler-Kielb, B. Coxon, A. Yergey, and R. Schneerson
A newly discovered cholesteryl galactoside from Borrelia burgdorferi
PNAS, June 24, 2003; 100(13): 7913 - 7918.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Rottem
Interaction of Mycoplasmas With Host Cells
Physiol Rev, April 1, 2003; 83(2): 417 - 432.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
S. Razin, D. Yogev, and Y. Naot
Molecular Biology and Pathogenicity of Mycoplasmas
Microbiol. Mol. Biol. Rev., December 1, 1998; 62(4): 1094 - 1156.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Sperling, U. Zahringer, and E. Heinz
A Sphingolipid Desaturase from Higher Plants. IDENTIFICATION OF A NEW CYTOCHROME b5 FUSION PROTEIN
J. Biol. Chem., October 30, 1998; 273(44): 28590 - 28596.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zähringer, U.
Right arrow Articles by Rottem, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zähringer, U.
Right arrow Articles by Rottem, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement